Prosperitas Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.28M Buy
19,664
+1,062
+6% +$236K 1.59% 27
2025
Q4
$4.25M Buy
18,602
+480
+3% +$109K 1.65% 22
2025
Q3
$4.2M Buy
18,122
+816
+5% +$166K 1.74% 20
2025
Q2
$3.21M Buy
17,306
+1,635
+10% +$304K 1.51% 25
2025
Q1
$3.28M Buy
15,671
+876
+6% +$170K 1.7% 22
2024
Q4
$2.63M Buy
14,795
+1,229
+9% +$226K 1.33% 29
2024
Q3
$2.68M Buy
13,566
+885
+7% +$165K 1.44% 25
2024
Q2
$2.18M Buy
12,681
+593
+5% +$98.2K 1.33% 26
2024
Q1
$2.2M Buy
12,088
+1,038
+9% +$179K 1.41% 23
2023
Q4
$1.71M Buy
11,050
+1,243
+13% +$181K 1.26% 25
2023
Q3
$1.46M Buy
+9,807
New +$1.44M 1.14% 24

Other funds holding ABBV

Prosperitas Financial's ABBV Position: Q1 2026 in Review

Prosperitas Financial increased its AbbVie (ABBV) stake by 5.7% in Q1 2026, buying an estimated $236K and bringing the position to 19,664 shares worth $4.28M. The position accounts for 1.59% of the portfolio, ranked #27.

Prosperitas Financial first reported a position in ABBV in Q3 2023 and has held it in 11 quarters since. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Prosperitas Financial held 19,664 shares of AbbVie worth $4.28M as of Q1 2026.
  • Prosperitas Financial bought 1,062 AbbVie shares in Q1 2026, an estimated $236K.
  • AbbVie made up 1.59% of Prosperitas Financial's portfolio in Q1 2026, its #27 holding.
  • Prosperitas Financial first reported a position in AbbVie in Q3 2023 and has held it in 11 quarters since.
  • 4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Prosperitas Financial's 13F filing for Q1 2026, filed 15 May 2026.